Aminex shows MYCN is a regulator of the polyamine pathway

Researchers from Aminex Therapeutics Inc. (Seattle, Wash.) and University of New South Wales showed that the MYCN oncogene is a direct regulator of

Read the full 230 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE